Cargando…
Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics
BACKGROUND: Glioblastoma multiforme (GBM) is a deadly brain tumour with minimal survival rates due to the ever-expanding heterogeneity, chemo and radioresistance. Kinases are known to crucially drive GBM pathology; however, a rationale therapeutic combination that can simultaneously inhibit multiple...
Autores principales: | Krishna, Aswani P., John, Sebastian, Shinde, Puja Laxmanrao, Mishra, Rashmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555349/ https://www.ncbi.nlm.nih.gov/pubmed/34715855 http://dx.doi.org/10.1186/s12935-021-02279-y |
Ejemplares similares
-
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme
por: Kirubakaran, Palani, et al.
Publicado: (2011) -
Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme
por: Fu, HuangDe, et al.
Publicado: (2019) -
At the crossroads of SUMO and NF-κB
por: Kracklauer, Martin P, et al.
Publicado: (2003) -
Understanding the Combined Effects of High Glucose Induced Hyper-Osmotic Stress and Oxygen Tension in the Progression of Tumourigenesis: From Mechanism to Anti-Cancer Therapeutics
por: G., Gayathri K., et al.
Publicado: (2023) -
Proteo : fábula /
por: Monterde, Francisco, 1894-1985
Publicado: (1944)